Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized pilot trial of lateral ridge augmentation with autogenous vs xenogenic bone blocks loaded with rhBMP-2
2012-002002-46Phase 3Completed
- Sponsor
- Universitätsklinik für Zahn-, Mund- und Kieferheilkunde, Med Uni Graz
- Start
- Apr 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of dibotermin alfa in Alveolar ridge defect, partial edentulism, sponsored by Universitätsklinik für Zahn-, Mund- und Kieferheilkunde, Med Uni Graz. Started Apr 2013; status: completed.
02
Drugs
dibotermin alfa
03
Conditions
Alveolar ridge defectpartial edentulism
Beyond the preview
Go deeper on 2012-002002-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002002-46.